Over two days it reviewed seven peptides and recommended six of them for the 503A compounding list: BPC-157 (8 yes, 6 no, 1 abstention), KPV, TB-500, and MOTS-c on day one, then epitalon and semax on day two
This is particularly relevant if youre working on: Metabolic health AOD-9604, MOTS-C, and BPC-157 offer complementary mechanisms to GLP-1 therapies Gut health BPC-157 and KPV target gut barrier integrity and inflammation Recovery and injury BPC-157 and TB-500 support tissue repair Hormonal balance Kisspeptin-10 and Thymosin Alpha-1 play roles in endocrine and immune regulation Healthy ageing GHK-Cu, Epitalon, and MOTS-C target fundamental ageing mechanisms If Youre Already a Meto Patient Were actively monitoring the regulatory developments and will update our treatment protocols as soon as these peptides become legally available through compounding pharmacies
If you want a broader look at the two core recovery compounds behind these formulas, read our BPC-157 and TB-500 healing peptides guide
The treatment also decreased pro-inflammatory and pro-fibrotic gene expression with reduced macrophage infiltration (Li et al., 2025)
Read on for the details
Further investigation could lead to new treatments for chronic conditions
